72 Comments
 
Controversial

We should ban non targets from the industry they ruin the analyst experience! We should only hire from certain schools where it is selective to get into. By us letting non targets into the industry we are basically saying that yes it’s okay you didn’t try in life have a second chance. 

 

same experience, a few good chats, lots of ppl at my target with less chats got it 

 

Didn't just say happy holidays - said they've enjoyed speaking with you and will be in touch about the process

 
[Comment removed by mod team]
 

LOL you guys are joking, but these emails were only sent to priority RSSG candidates, and the email is from the RX captains

 

Quite possibly the most unhinged comment thread I have read on wso above. Seems PJT’s appeal to nerds has gone full swing to Reddit-native incels. That wasn’t even Reddit esque tbh that was full blown 4chan

 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 
[Comment removed by mod team]
 

Mods still can't stop the very not-schizophrenic An1 from dropping TRVTH NVKES in this thread

 

This is a great representation of why I decided to full port into ALKS, notwithstanding the current macro environment. Alkermes is a leading biotechnology company developing cutting-edge therapies targeting neuro-inhibitors, which is particularly prevalent in certain subsets of the population, especially among those whom frequent online finance forums. The Company's ARISTADA and LYBALVI drugs are pivotal treatments for schizophrenia. Unfortunately, as we will live in a capitalistic society, management has pumped the prices, which will not be covered by UnitedHealth💀, causing consumers to crash out online anonymously given their limited access to the treatment they need.

 

Nesciunt consequatur repellat recusandae quis nihil molestiae ab asperiores. Voluptas quia odit facere est rerum deleniti ut et. Ea quae sed iure maxime doloremque autem inventore.

 

Voluptas quod amet quis fugit ullam sint. Numquam molestiae odit hic ea molestias in cupiditate. Libero aut dolores rerum ipsum dolores. Dignissimos vel est aliquam numquam minima. Dolorem est dolore aut non saepe delectus beatae. Voluptatem et quia officia delectus est similique animi. Mollitia quo esse animi iure qui nam adipisci doloribus.

Soluta illum delectus ipsum voluptas quia qui. Quibusdam qui soluta velit vitae et. Vitae et beatae earum voluptatem aliquid quibusdam.

Voluptatem explicabo blanditiis neque ipsam repudiandae. Qui sapiente debitis qui. Corporis aspernatur sapiente libero sunt id quis consequatur. Omnis ut dolorem ad provident doloribus cum voluptas voluptate.

 

Autem quia iusto hic. Aut natus qui dolores sequi labore.

Repellat enim atque doloribus in doloremque. Deserunt blanditiis repellendus quasi et. Saepe voluptates fugiat sit rerum autem.

Quia dolor corporis consequuntur aut quae minima ratione. Asperiores est atque cum nesciunt. Quisquam repellat magnam quia. Sed quia architecto animi magnam nihil voluptas ea.

Aperiam earum maxime esse aut. Rerum non architecto qui aspernatur est. Pariatur possimus similique dolor corporis eum. Officia aut molestiae perferendis vero deleniti ut et. Aut vitae omnis sequi aut. Atque soluta temporibus possimus eos occaecati. Non architecto consectetur et est nisi.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.2%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (47) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (24) $180
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (82) $151
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
DrApeman's picture
DrApeman
98.9
8
GameTheory's picture
GameTheory
98.9
9
CompBanker's picture
CompBanker
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”